EU Drug Regulatory Network Faces Up To An Uncertain And Complex Future
Tasks To Be Shared By EMA And National Regulators
Regulators have produced yet another strategy outlining the challenges and next steps for the European drug regulatory network as the network prepares for a future characterized by rapid developments in science and technology, medicines access issues, supply chain weaknesses and emerging health threats.
